SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-103757
Filing Date
2023-04-17
Accepted
2023-04-17 16:51:51
Documents
10
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A d274068ddef14a.htm DEF 14A 388302
2 GRAPHIC g274068g00r37.jpg GRAPHIC 4229
3 GRAPHIC g274068g00r38.jpg GRAPHIC 2057
4 GRAPHIC g274068g01r37.jpg GRAPHIC 2276
5 GRAPHIC g274068g02r37.jpg GRAPHIC 2007
6 GRAPHIC g274068g03r37.jpg GRAPHIC 2297
7 GRAPHIC g274068g04r37.jpg GRAPHIC 2360
8 GRAPHIC g274068g41o23.jpg GRAPHIC 24843
9 GRAPHIC g274068g56o91.jpg GRAPHIC 35844
10 GRAPHIC g274068xlogo.jpg GRAPHIC 8211
  Complete submission text file 0001193125-23-103757.txt   497156
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40800 | Film No.: 23824520
SIC: 2834 Pharmaceutical Preparations